Advances in the Prevention and Long-Term Management of Venous Thromboembolism

http://academiccme.com/wp-content/uploads/2017/11/iStock-641133986-wpcf_400x400.jpg

Course Information

Therapautic Area: Cardiology, Hematology, Pulmonolgy
Format(s): Webcast
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: October 15, 2017 to October 14, 2018

 

Program Overview

This CME webcast will focus on the advances in the prevention and long-term management of venous thromboembolism (VTE). The expert faculty will review the current CHEST guidelines consisting of the prophylaxis of VTE, biomarkers, and therapeutic targets. An analysis of the efficacy, safety and recent clinical trial data of novel therapies will be discussed. The faculty will also review how to develop data-driven treatment regimens for the healthcare team to optimally manage patients at risk for VTE. Upon completion of this activity, learners will have a better understanding of the prevention and management of VTE, ultimately improving patient outcomes.

Target Audience

Internists, primary care physicians, pulmonologists, cardiologists, hospitalists, nurse practitioners, nurses and other healthcare professionals who care for patients with VTE.

Learning Objectives

  1. Review current CHEST guidelines for the prophylaxis of VTE, biomarkers, and therapeutic targets.
  2. Analyze efficacy, safety, and clinical trial data of novel therapies for the prevention and extended management of patients with VTE.
  3. Develop data-driven treatment regimens for the healthcare team to optimally manage patients at risk for VTE.

Faculty

Pollack_Headshot

Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP
Professor of Emergency Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania

 

 

MerliGeno J. Merli, MD, MACP, FSVM, FHM
Professor Medicine & Surgery
Sidney Kimmel Medical College
Thomas Jefferson University Hospitals
Philadelphia, Pennsylvania

 

 

StewartJohn Stewart, MD, FACP
Assistant Professor
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania

 

 

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Faculty Relationship Identified With:
Charles Pollack, MD Consultant/Advisor: Bristol-Myers Squibb Company; Boehringer Ingelheim; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; Portola Pharmaceuticals, Inc.;
Grant/Research Support: Boehringer Ingelheim; CSL Behring; DAIICHI SANKYO COMPANY, LIMITED.; Janssen Pharmaceuticals, Inc.; Portola Pharmaceuticals, Inc.
Geno Merli, MD Consultant/Advisor: Bristol-Myers Squibb Company; Johnson & Johnson Services, Inc.; sanofi-aventis U.S. LLC.;
Grant/Research Support: Bristol-Myers Squibb Company; Johnson & Johnson Services, Inc.; sanofi-aventis U.S. LLC.; Portola Pharmaceuticals, Inc.; Janssen Scientific Affairs, LLC.
John Stewart, MD Consultant/Advisor: F. Hoffmann-La Roche Ltd.

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski; Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Portola Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Portola Pharmaceuticals, Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact admin@academiccme.com.
BUTTON


Provided by AcademicCME-web